RE:RE:RE:RE:RE:RE:RE:Bevcanna's Pure Therapy Reports Record Monthly Revenue I must be reading the financials wrong. I see 1.5 million in convertable debenture, no more convertable loan left and 76.9 million in overall dept. What numbers did you find?
As for the remainder of what you said, Bevcanna won't merge with Sproutly while they have so much dept regardless of the type of dept but for sure that could happen once the debt has been removed. And for sure on the OILS technology piece. I have long seen Sproutly's process as something attractive to Bevcanna and a natural fit, but then there are also a lot of other companies seeking such technology.
I'll keep watching Sproutly's debt ratio and see how it pans out. If you have differnet numbers than myself, please let me see them and if you can indicate what columns in the financials you got them from. I am not as good with financials as I wish I were :(